Last update 01 Nov 2024
Recombinant human nerve growth factor(Sichuan ZehaTimes Pharmaceutical Co. Ltd.)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Growth factors |
Synonyms- |
Target |
Mechanism p75NTR agonists(Low affinity neurotrophin receptor p75NTR agonists), Neurons stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Recombinant human nerve growth factor(Sichuan ZehaTimes Pharmaceutical Co. Ltd.)注射用重组人神经生长因子在非动脉炎性前部缺血性视神经病变患者中的
多中心、随机、双盲、安慰剂合并基础治疗、平行对照 II 期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-combined basic treatment, parallel-controlled phase II clinical trial of recombinant human nerve growth factor for injection in patients with non-arteritic anterior ischemic optic neuropathy
注射用重组人神经生长因子单中心、随机、双盲、安慰剂对照的单次/多次给药耐受性及药代动力学研究
[Translation] A single-center, randomized, double-blind, placebo-controlled study on the tolerability and pharmacokinetics of single/multiple doses of recombinant human nerve growth factor for injection
A single center, randomized, double-blind, placebo-controlled single / multiple dose tolerance and pharmacokinetics study of recombinant human nerve growth factor for injection
100 Clinical Results associated with Recombinant human nerve growth factor(Sichuan ZehaTimes Pharmaceutical Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant human nerve growth factor(Sichuan ZehaTimes Pharmaceutical Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant human nerve growth factor(Sichuan ZehaTimes Pharmaceutical Co. Ltd.)
Login to view more data
100 Deals associated with Recombinant human nerve growth factor(Sichuan ZehaTimes Pharmaceutical Co. Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Optic Nerve Injuries | Phase 2 | CN | 29 Dec 2023 | |
| Optic Nerve Injuries | Phase 2 | CN | 29 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free